IRCT2014012110417N3已完成2 期
Efficacy of adjuvant levamisole user and levamisole non-user with hepatitis B vaccination in vaccine non-responders health care workers
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •employees who have a history of hepatitis B vaccination and they aren’t immunized against this disease (HBsAb under 10); completing an informed consent form.
- •Exclusion criteria: employees with history or facing with positive HBsAg and HBcAb hepatitis
排除标准
- 未提供
研究者
相似试验
已完成
3 期
The role of levamisole co-administration hepatitis B vaccine in immunization.eed for immunization against viral hepatitis.Persons with potential health hazards related to communicable diseasesIRCT2014110618915N2Mashad University of Medical Sciences217
进行中（未招募）
1 期
AEUCTR2016-002324-92-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)156
招募中
不适用
Prevention of the return of nephrotic syndrome in children by adding levamisole to standard prednisone treatment. Het voorkomen van terugval van het nefrotisch syndroom bij kinderen door het toevoegen van levamisol aan de standaardbehandelng met prednison.NL-OMON27331Academic Medical Center (AMC)Postbus 22600 1100 DD AmsterdamThe Netherlands+31 (0)20 566 911192
招募中
3 期
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatment2024-517467-23-00Amsterdam UMC Stichting87
进行中（未招募）
1 期
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatmentEUCTR2017-001025-41-BEAmsterdam University Medical Center, location AMC92